Caligan Partners LP
Q3 2025 13F Holdings
- Locationnew york, NY
- Num holdings
18
- Value ($000)
$763,509
- Date Filed11/14/2025
- Form type13F-HR
- CIK0001727492
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
LQDA LIQUIDIA CORPORATION | COM NEW | 53635D202 | $184.62 M | 24 % | 8,118,892 | ||
ABIVAX SA | SPONSORED ADS | 00370M103 | $123.27 M | 16 % | 1,451,924 | ||
MLYS MINERALYS THERAPEUTICS INC | COM | 603170101 | $105.14 M | 14 % | 2,772,654 | ||
EX9 EXELIXIS INC | COM | 30161Q104 | $63.01 M | 8 % | 1,525,730 | ||
RVMD REVOLUTION MEDICINES INC | COM | 76155X100 | $49.70 M | 7 % | 1,064,249 | ||
AGIO AGIOS PHARMACEUTICALS INC | COM | 00847X104 | $45.41 M | 6 % | 1,131,205 | ||
AGIO AGIOS PHARMACEUTICALS INC | COM | 00847X104 | $39.14 M | 5 % | 975,000 | put | |
ADMA ADMA BIOLOGICS INC | COM | 000899104 | $38.65 M | 5 % | 2,636,609 | ||
EOLS EVOLUS INC | COM | 30052C107 | $25.41 M | 3 % | 4,138,943 | ||
MERUS N V | COM | N5749R100 | $20.43 M | 3 % | 216,954 |
Rows Per Page
10
- 10
- 50
- 100